Literature DB >> 10632573

Geldanamycin induces cell cycle arrest in K562 erythroleukemic cells.

H R Kim1, C H Lee, Y H Choi, H S Kang, H D Kim.   

Abstract

Geldanamycin (GA), a benzoquinone ansamycin, is one of the specific inhibitors of 90-kDa heat shock protein and induces growth inhibition and apoptosis in certain cancer cell lines. We have investigated the mechanism of GA-induced growth inhibition in K562 erythroleukemic cells. DNA flow-cytometric analysis indicated that GA-induced growth arrest was associated with G2/M phase arrest of the cell cycle. GA treatment down-regulated the expression of cyclin B1 and inhibited phosphorylation of Cdc2 protein, both key regulatory proteins at the G2/M boundary. GA also markedly inhibited the Cdc2 kinase activity, which may be in part a result of up-regulation of p27KIP1 by GA. The present results suggest a novel mechanism that p27KIP1 could be involved in the regulation of G2 to M phase transition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632573     DOI: 10.1080/713803539

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  9 in total

Review 1.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

2.  Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis.

Authors:  Lisa Pham; Lisa Christadore; Scott Schaus; Eric D Kolaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

3.  Systematic identification of the HSP90 candidate regulated proteome.

Authors:  Zhixiang Wu; Amin Moghaddas Gholami; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2012-02-14       Impact factor: 5.911

4.  Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation.

Authors:  Sebastian E B Graefe; Martina Wiesgigl; Iris Gaworski; Andrea Macdonald; Joachim Clos
Journal:  Eukaryot Cell       Date:  2002-12

Review 5.  Heat Shock Proteins as the Druggable Targets in Leishmaniasis: Promises and Perils.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

6.  Induction of premature senescence by hsp90 inhibition in small cell lung cancer.

Authors:  Ian J Restall; Ian A J Lorimer
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

7.  Leishmania donovani 90 kD Heat Shock Protein - Impact of Phosphosites on Parasite Fitness, Infectivity and Casein Kinase Affinity.

Authors:  Antje Hombach-Barrigah; Katharina Bartsch; Despina Smirlis; Heidi Rosenqvist; Andrea MacDonald; Florent Dingli; Damarys Loew; Gerald F Späth; Najma Rachidi; Martin Wiese; Joachim Clos
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

Review 8.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

9.  Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo.

Authors:  Wenqian Wang; Yang Liu; Zhixin Zhao; Chengying Xie; Yongping Xu; Youhong Hu; Haitian Quan; Liguang Lou
Journal:  Cancer Sci       Date:  2016-04-27       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.